Literature DB >> 7188380

Generation of highly metastatic tumors in DBA/2 mice. Oncogenicity of a strain tumor cells.

P Frost, R S Kerbel, R Tartamella-Biondo.   

Abstract

The sequential intraperitoneal injection of five different A strain tumors into DBA/2 mice resulted in the de novo generation of new DBA/2 tumors. These new tumors share many identical characteristics including the expression of surface H2d, FcR, LY6.2 and tumor antigens. All have the same karyotype which differs in number and in the presence of two metacentric chromosomes from the original A strain tumors. Phenotypically, all are vigorously metastatic after intraperitoneal, subcutaneous, intradermal or intravenous injection. None of the original A strain tumors are metastatic in the A strain host. These tumors have thus provided us with a good model for the study of metastasis while raising questions regarding the oncogenicity of tumors.

Entities:  

Mesh:

Year:  1981        PMID: 7188380

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  9 in total

1.  Tumor heterogeneity: biological implications and therapeutic consequences.

Authors:  G H Heppner; B E Miller
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

2.  Clonal analysis of expression of tumor-associated transplantation antigens and of metastatic capacity.

Authors:  V Schirrmacher; K Bosslet
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

Review 3.  Nonmetastatic tumor cells acquire metastatic properties following somatic hybridization with normal cells.

Authors:  P De Baetselier; E Roos; L Brys; L Remels; M Gobert; D Dekegel; S Segal; M Feldman
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

Review 4.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 5.  Influence of implantation site on formation of metastases.

Authors:  C Meyvisch
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 6.  Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.

Authors:  R S Kerbel; J W Dennis; A E Largarde; P Frost
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

7.  Mutagen-induced Imm+ variants: the need for viable and cloned Imm+ variants for effective protection against a primary murine tumor and its metastases.

Authors:  A Sella; B Hunt; P Frost
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

8.  Can cancer cells transform normal host cells into malignant cells?

Authors:  S Pathak; M A Nemeth; A S Multani; G N Thalmann; A C von Eschenbach; L W Chung
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.

Authors:  P Frost; R G Liteplo; T P Donaghue; R S Kerbel
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.